Targeting succinate metabolism to decrease brain injury upon mechanical thrombectomy treatment of ischemic stroke.
Targeting succinate metabolism to decrease brain injury upon mechanical thrombectomy treatment of ischemic stroke.
复制标题
DOI:
10.1016/j.redox.2023.102600
复制
发表时间:
2023-03
期刊:
影响因子:
11.4
通讯作者:
Krieg, Thomas
中科院分区:
文献类型:
--
作者:
Mottahedin, Amin;Prag, Hiran A.;Dannhorn, Andreas;Mair, Richard;Schmidt, Christina;Yang, Ming;Sorby-Adams, Annabel;Lee, Jordan J.;Burger, Nils;Kulaveerasingam, Duvaraka;Huang, Margaret M.;Pluchino, Stefano;Peruzzotti-Jametti, Luca;Goodwin, Richard;Frezza, Christian;Murphy, Michael P.;Krieg, Thomas
Current treatments for acute ischemic stroke aim to reinstate a normal perfusion in the ischemic territory but can also cause significant ischemia-reperfusion (IR) injury. Previous data in experimental models of stroke show that ischemia leads to the accumulation of succinate, and, upon reperfusion, the accumulated succinate is rapidly oxidized by succinate dehydrogenase (SDH) to drive superoxide production at mitochondrial complex I. Despite this process initiating IR injury and causing further tissue damage, the potential of targeting succinate metabolism to minimize IR injury remains unexplored. Using both quantitative and untargeted high-resolution metabolomics, we show a time-dependent accumulation of succinate in both human and mouse brain exposed to ischemia ex vivo. In a mouse model of ischemic stroke/mechanical thrombectomy mass spectrometry imaging (MSI) shows that succinate accumulation is confined to the ischemic region, and that the accumulated succinate is rapidly oxidized upon reperfusion. Targeting succinate oxidation by systemic infusion of the SDH inhibitor malonate upon reperfusion leads to a dose-dependent decrease in acute brain injury. Together these findings support targeting succinate metabolism upon reperfusion to decrease IR injury as a valuable adjunct to mechanical thrombectomy in ischemic stroke.
登录
查看更多内容
影响因子:
16.6
作者:
Yin Z;Burger N;Kula-Alwar D;Aksentijević D;Bridges HR;Prag HA;Grba DN;Viscomi C;James AM;Mottahedin A;Krieg T;Murphy MP;Hirst J
通讯作者:
Hirst J
影响因子:
2.1
作者:
Tang, Yuan;Horikoshi, Masaaki;Li, Wenxuan
通讯作者:
Li, Wenxuan
DOI:
10.1016/s1474-4422(12)70203-x
发表时间:
2012-10
期刊:
The Lancet. Neurology
影响因子:
--
作者:
Lansberg MG;Straka M;Kemp S;Mlynash M;Wechsler LR;Jovin TG;Wilder MJ;Lutsep HL;Czartoski TJ;Bernstein RA;Chang CW;Warach S;Fazekas F;Inoue M;Tipirneni A;Hamilton SA;Zaharchuk G;Marks MP;Bammer R;Albers GW;DEFUSE 2 study investigators
通讯作者:
DEFUSE 2 study investigators
DOI:
10.1093/brain/awaa264
发表时间:
2020-12-05
期刊:
Brain : a journal of neurology
影响因子:
--
作者:
Li Y;Wang T;Zhang T;Lin Z;Li Y;Guo R;Zhao Y;Meng Z;Liu J;Yu X;Liang ZP;Nachev P
通讯作者:
Nachev P
影响因子:
64.8
作者:
Chouchani, Edward T.;Pell, Victoria R.;Gaude, Edoardo;Aksentijevic, Dunja;Sundier, Stephanie Y.;Robb, Ellen L.;Logan, Angela;Nadtochiy, Sergiy M.;Ord, Emily N. J.;Smith, Anthony C.;Eyassu, Filmon;Shirley, Rachel;Hu, Chou-Hui;Dare, Anna J.;James, Andrew M.;Rogatti, Sebastian;Hartley, Richard C.;Eaton, Simon;Costa, Ana S. H.;Brookes, Paul S.;Davidson, Sean M.;Duchen, Michael R.;Saeb-Parsy, Kourosh;Shattock, Michael J.;Robinson, Alan J.;Work, Lorraine M.;Frezza, Christian;Krieg, Thomas;Murphy, Michael P.
通讯作者:
Murphy, Michael P.